iPierian Receives $6,000,000 Series B Financing Round

  • Feed Type
  • Date
    9/8/2010
  • Company Name
    iPierian
  • Mailing Address
    951 Gateway Blvd South San Francisco, CA 94080
  • Company Description
    iPierian is a pioneering biopharmaceutical company that is taking the cutting-edge technologies of cellular reprogramming and directed differentiation to an entirely new level to harness the power of induced pluripotent stem cells to advance the understanding of human diseases and accelerate the discovery of more effective therapeutics for patients.
  • Website
    http://www.ipierian.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This financing will allow the company to drive its programs into the clinic, while securing pharmaceutical partnerships.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Biogen Idec Inc.

Trending on Xconomy